CN201834922U - Fungus drug sensitivity test board - Google Patents
Fungus drug sensitivity test board Download PDFInfo
- Publication number
- CN201834922U CN201834922U CN2010201888205U CN201020188820U CN201834922U CN 201834922 U CN201834922 U CN 201834922U CN 2010201888205 U CN2010201888205 U CN 2010201888205U CN 201020188820 U CN201020188820 U CN 201020188820U CN 201834922 U CN201834922 U CN 201834922U
- Authority
- CN
- China
- Prior art keywords
- test
- hole
- drug sensitivity
- test hole
- drug sensitive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Abstract
The utility model discloses a fungus drug sensitivity test board, aiming at providing a high-efficiency, rapid and accurate fungus drug sensitivity test board. The fungus drug sensitivity test board comprises a drug sensitivity test board body (1) and a board cover body (2), wherein the board cover body (2) is in close fit with the drug sensitivity test board body (1) and the drug sensitivity test board body (1) is provided with at least one row of test holes (3). Each row of test holes (3) comprises a plurality of test holes (3). The internal part of each test hole (3) is covered by coating substances. A drug bottle placing hole (5) is arranged at one end of the drug sensitivity test board body (1). The fungus drug sensitivity test board can be used for simultaneously conducting drug sensitivity tests to kinds of antibiotic drugs, the testing, the drug selection and the treatment are enabled to be faster and more efficient, and the fungus drug sensitivity test board can be widely used in the fields of in vitro diagnosis and drug sensitivity tests.
Description
Technical field
The utility model relates to a kind of fungal drug sensitive check-out console.
Background technology
Mycosis is that people often run in daily life, comprises tinea, tinea unguium, pulmonary mycosis, stomach mycosis, otomycosis etc.And moniliosis and cryptococcosis are modal two kinds of mycosises.Moniliosis mainly is acute, the subacute or chronic infection that Candida albicans causes, often invades skin, mucous membrane, also can cause internal organ or systemic infection.Clinical symptom is intricate, anxious slow differing.When the monilial infection symptom appearred in patient, medical personnel are many can to use miconazole, nystatin, clotrimazole, miconazole, and econazole, medicines such as butoconazole are patient.Cryptococcosis can be invaded humans and animals, is generally exogenous infection, also may be autogenous infection, and for human, normally condition is pathogenic for it.Cryptococcus neoformans can be sent out to whole body when the human body lower immune function, mainly invades central nervous system, and meningitis, encephalitis, cerebral granuloma etc. take place, and can invade bone, muscle, lymphoglandula, mucocutaneous chronic inflammatory diseases and the abscess of causing in addition.The widely used medicine of medical personnel has potassiumiodide, sodium iodide, garlic essence, amphotericin B etc.
Antibacterials have played important effect to mycotic control, but owing to not science, the blindness of medication process are abused antibacterials, thereby caused a lot of pathogenic funguses to produce resistance.In recent years along with the application of heavy dose of microbiotic, hormone, immunosuppressor, and the carrying out of transplant operation, antibacterials not only cause drug waste to mycotic control effect worse and worse, but also have incured loss through delay patient's the state of an illness.At present, the application of antibiotic drug is very extensive, and various pathogenic bacterias are to the susceptibility difference of antibiotic medicine, and the different strains of bacterium of the same race is also variant to the susceptibility of same medicine.Whether can accurately hold the dosage of antibacterials and pathogenic bacteria to the relation between the susceptibility of antibacterials, just become and quick and precisely treat mycotic key.At present the fungal drug sensitive check-out console that generally adopts is single certain medicine to be tested, and has limited the property rapidly and efficiently of whole process thus to a great extent, and influence is to effective control of pathophoresis with to the good treatment of disease.
The utility model content
Technical problem to be solved in the utility model is to overcome the deficiencies in the prior art, provide a kind of efficiently, fungal drug sensitive check-out console efficiently.
The technical scheme that the utility model adopted is: the utility model comprises antibiotics susceptibility test plate body, plate lid, described plate lid and described antibiotics susceptibility test plate body closely cooperate, described antibiotics susceptibility test plate body is provided with at least one row's test hole, each row all can be provided with several described test holes on request, is coated with encrusting substance in the described test hole; One end of described antibiotics susceptibility test plate body also can be provided with one or more medicine bottle putting holes as required, be used to place and just using or standby antibiotic drug medicine bottle, the other medicine that is provided with of described test hole indicates symbol, be used for indicating the classification that each test hole is wanted testing drug, handled easily, minimizing error.
Also include feminine gender, positive control hole on the described antibiotics susceptibility test plate body, in described negative control hole, add a certain amount of pollution-free fungal drug sensitive nutrient solution, in test, be used to carry out blank; Described positive control hole is self positive control hole; The number of described test hole is provided with as required, and can be divided into many rows, every row's the different antibiotic drug of described test hole endoperidium, two rows or arrange the test hole bag by the antibiotic drug of the same race of different concns more; Prepare bacteria suspension, a certain amount of described bacteria suspension is sneaked in the described fungal drug sensitive nutrient solution, and make described bacteria suspension uniform distribution in described fungal drug sensitive nutrient solution; Described bacteria suspension one by one is added in all the other described test holes with a certain amount of; Place the fungal drug sensitive nutrient solution of described interpolation bacteria suspension 35～37 ℃ environment to cultivate, see its look become with record sensitivity, in result such as quick, resistance, measured result is significant to clinical treatment and medication; Experience and antibiotic drug kind commonly used according to susceptibility detects can described test hole optimization be set to two rows, and seven test holes of every row carry out fungal drug sensitive simultaneously to seven kinds of different antibiotic drugs commonly used and detect.
The beneficial effects of the utility model are: the utility model is provided with some test holes, can be simultaneously carry out fungal drug sensitive to multiple antibiotic drug and detect, and makes detections, selects medicine, treatment is faster efficiently; The utility model is provided with the medicine bottle putting hole at an end of antibiotics susceptibility test plate body, is used to place just using or standby antibiotic drug medicine bottle, brings convenience to operating process; The other medicine that is provided with of test hole of the present utility model indicates symbol, as-,+, all kinds of antibiotic drug code names etc., indicate the antibiotic drug classification in each test hole thus, make things convenient for the staff to operate, prevent to produce error because of obscuring.
Description of drawings
Fig. 1 is the utility model antibiotics susceptibility test plate main body structure synoptic diagram;
Fig. 2 is an A-A sectional view shown in Figure 1;
Fig. 3 is the structural representation of the utility model plate lid.
Embodiment
As Fig. 1, Fig. 2, shown in Figure 3, the utility model comprises antibiotics susceptibility test plate body 1, plate lid 2, described plate lid 2 closely cooperates with described antibiotics susceptibility test plate body 1, described antibiotics susceptibility test plate body 1 is provided with test hole 3, be coated with encrusting substance in the described test hole 3, described test hole 3 can be divided into plurality of rows as required, and every row can be provided with several described test holes 3 on request, in the present embodiment, described test hole 3 is set to two rows, seven test holes of every row, wherein a row is the lower concentration test hole, another row is height degree test hole.Comprising amphotericin B (AMB) test hole 31, nystatin (NYS) test hole 32, econazole (ECO) test hole 33, miconazole (MIC) test hole 34, KETOKONAZOL (KET) test hole 35, fluconazole (FLU) test hole 36, itraconazole (ITR) test hole 37; One end of described antibiotics susceptibility test plate body 1 also can be provided with one or more medicine bottle putting holes 5 as required, present embodiment is provided with a medicine bottle putting hole, be used to place and just using or standby antibiotic drug medicine bottle, described negative control hole A1, described positive control hole B1, the described test hole 3 other medicines that are provided with indicate symbol 4, are used for indicating the classification of each test hole antibiotic drug.
When the professional operated, described negative control hole A1 inoculated described fungal drug sensitive nutrient solution, was used to carry out blank in test; B1 is self positive control hole.Prepare bacteria suspension, this bacteria suspension must use after preparation immediately.Draw 100 μ L bacteria suspensions and sneak into described fungal drug sensitive nutrient solution, shake up; Continue and respectively add 150 μ L bacteria suspensions in all the other described test holes with sample injector; Add 1-2 to each described test hole and drip sterile mineral oil, make it not infected with good each test hole of capping.Place 35～37 ℃ to cultivate observations after 12～24 hours the described fungal drug sensitive nutrient solution that is added with bacteria suspension; When described B1 positive control hole becomes tawny, can report the antibiotics susceptibility test result, according to described test hole change in color, judge that respectively relative medicine is: responsive, in quick, resistance, its corresponding symbol is: "--", "+-", " ++ ", wherein '-' number represents that described test hole still is purple, color and the solid colour of described positive control hole B1, the i.e. tawny of the described test hole of '+' expression.For example, for described amphotericin B (AMB), the back result is after tested: showing purple during A is capable, show purple during B is capable, then is responsive; If A shows purple in capable, show tawny during B is capable, quick in then being; If be shown as tawny during A is capable, be shown as tawny during B is capable, then be resistance; All the other described antibiotic drugs: the test result of nystatin (NYS), econazole (ECO), miconazole (MIC), KETOKONAZOL (KET), fluconazole (FLU), itraconazole (ITR) all can judge by above-mentioned way.Measured result is significant to clinical treatment and medication.
Claims (5)
1. fungal drug sensitive check-out console, described fungal drug sensitive check-out console comprises antibiotics susceptibility test plate body (1), plate lid (2), described antibiotics susceptibility test plate body (1) closely cooperates with described plate lid (2), described fungal drug sensitive check-out console adopts transparent material, it is characterized in that: described antibiotics susceptibility test plate body (1) is provided with at least one row's test hole (3), several described test holes (3) are drawn together in every package, and described test hole is coated with encrusting substance in (3).
2. fungal drug sensitive check-out console according to claim 1 is characterized in that: described test hole (3) is divided into two rows, and wherein a row is the lower concentration test hole, and another row is the high density test hole.
3. fungal drug sensitive check-out console according to claim 2, it is characterized in that: the every row of described test hole (3) is provided with seven, and described seven test holes (3) are respectively amphotericin B test hole (31), nystatin test hole (32), econazole test hole (33), miconazole test hole (34), KETOKONAZOL test hole (35), fluconazole test hole (36), itraconazole test hole (37).
4. fungal drug sensitive check-out console according to claim 3, it is characterized in that: also be provided with negative control hole (A1), positive control hole (B1) on the described antibiotics susceptibility test plate body (1), described negative control hole (A1), described positive control hole (B1), other being provided with of described test hole (3) indicate symbol (4).
5. according to right 1 to 4 arbitrary described fungal drug sensitive check-out console, it is characterized in that: an end of described antibiotics susceptibility test plate body (1) also is provided with medicine bottle putting hole (5).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010201888205U CN201834922U (en) | 2010-05-05 | 2010-05-05 | Fungus drug sensitivity test board |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010201888205U CN201834922U (en) | 2010-05-05 | 2010-05-05 | Fungus drug sensitivity test board |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201834922U true CN201834922U (en) | 2011-05-18 |
Family
ID=44005027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010201888205U Expired - Lifetime CN201834922U (en) | 2010-05-05 | 2010-05-05 | Fungus drug sensitivity test board |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201834922U (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102818888A (en) * | 2012-07-31 | 2012-12-12 | 白仲虎 | Test box |
| CN102818897A (en) * | 2012-07-31 | 2012-12-12 | 白仲虎 | Detection device |
| CN107723228A (en) * | 2017-09-20 | 2018-02-23 | 凤阳高科动物保健品厂 | A kind of veterinary antibiotic susceptibility Quick testing box |
-
2010
- 2010-05-05 CN CN2010201888205U patent/CN201834922U/en not_active Expired - Lifetime
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102818888A (en) * | 2012-07-31 | 2012-12-12 | 白仲虎 | Test box |
| CN102818897A (en) * | 2012-07-31 | 2012-12-12 | 白仲虎 | Detection device |
| CN107723228A (en) * | 2017-09-20 | 2018-02-23 | 凤阳高科动物保健品厂 | A kind of veterinary antibiotic susceptibility Quick testing box |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN201834922U (en) | Fungus drug sensitivity test board | |
| CN101519688A (en) | Detection method for drug resistant genes of Klebsiella pneumoniae against belta-lactamase | |
| Farrow et al. | Developing a real time sensing system to monitor bacteria in wound dressings | |
| Nix et al. | Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis | |
| CN107519167B (en) | Candida albicans resistant product combining harmine hydrochloride and fluconazole and application thereof | |
| CN101886111A (en) | Fungus rapid culture, identification and susceptibility detection kit and detection method thereof | |
| CN101760502B (en) | Method for rapidly determining drug tolerance of strain | |
| Gajda | Heart rate monitor instead of ablation? Atrioventricular nodal re-entrant tachycardia in a leisure-time triathlete: 6-year follow-up | |
| CN110951822A (en) | Bacterial drug sensitivity detection method suitable for drug sensitivity plate | |
| NZ529354A (en) | Diagnosis by sensing volatile components | |
| CN201107274Y (en) | Mycoplasma drug sensitive test board | |
| CN205133582U (en) | Genetic chip that layering set up | |
| CN207012188U (en) | Multifunctional blood sugar instrument | |
| CN201678682U (en) | Susceptibility test kit capable of rapidly identifying pathogenic fungi through culturing | |
| CN108498784A (en) | Application of the Radix pseudostellariae cyclic peptides B in preparing anti-candida albicans drug | |
| CN203048943U (en) | Kit with fungi identification and fast drug sensitivity test functions | |
| CN202063921U (en) | Full-automatic blood culture instrument | |
| CN105219636B (en) | A kind of drug sensitive batten and preparation method thereof | |
| CN101601863A (en) | A kind of construction method of diabetes animal model | |
| CN205554946U (en) | External kit | |
| CN201298022Y (en) | A drug sensitivity detecting board | |
| CN203117153U (en) | Biosensor for quickly detecting residual amount of tetracycline and hydroquinone | |
| CN106176801B (en) | Application of hydrogen sulfide in preparation of medicine for treating inflammatory anemia | |
| CN2433626Y (en) | Composite drug sensitive test paper | |
| CN106755279A (en) | Nutrient solution, kit and detection method for detection bacterium vaginitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: ZHUHAI YINKE MEDICAL ENGINEERING CO., LTD. Free format text: FORMER NAME: ZHUHAI ENCODE MEDICAL ENGINEERING CO., LTD. |
|
| CP03 | Change of name, title or address |
Address after: Jinwan District Hongqi Industrial Park Hong Hui two road 519090 Guangdong city of Zhuhai province No. 020 Patentee after: Zhuhai silvertech medical engineering Limited by Share Ltd Address before: 519090 Guangdong city of Zhuhai province Jinwan District Hongqi Industrial Park, Hong Fai Road two Patentee before: Encode Medical Engineering Co., Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20110518 |
|
| CX01 | Expiry of patent term |